Loading

Slzii.com Search

Search (News)

Kelun-Biotech Presents Pivotal Phase II Data For Lunbotinib Fumarate (A400/EP0031) In RET Fusion-Positive NSCLC At 2026 ASCO

Kelun-Biotech Presents Pivotal Phase II Data For Lunbotinib Fumarate (A400/EP0031) In RET Fusion-Positive NSCLC At 2026 ASCO
english science technology top

(MENAFN - PR Newswire) CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990) announced that at the 2026 American Society of Clinical ...
2026-05-29 23:46:09

What are you doing?
0.097579002380371


News
News

Latest News and Headlines
(MENAFN - PR Newswire) CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the Company, 6990) ...
News